In patients undergoing TAVR, CpcPH patients had the numerically highest mortality according to both the 2015 [HR 1.66 (95% CI 0.60–4.62); P = 0.33] and 2022 [HR 4.92 (95% CI 0.64–37.88); P = 0.13] definitions, but due to the limited number of patients in this subgroup, this failed to reach statistical significance (see Supplementary material online , Figures S1 and S2 ).
← all excerpts
Impact of the 2022 pulmonary hypertension definition on haemodynamic classification and mortality in patients with aortic stenosis undergoing valve replacement.
1
—
—